sanofi-aventis, Xceleron Ltd. deal

Xceleron will provide its accelerator mass spectrometry services to SAN's sanofi-aventis Deutschland GmbH subsidiary for use in microdosing studies and metabolite profiling in Phase I trials. Further ...